Skip to main content
logo
Sunrest Lifescience Limited (NSE:SUNREST)
India flag India · Delayed Price · Currency is INR
41.00
-1.15 (-2.73%)
Aug 21, 2026, 2:55 PM IST

Sunrest Lifescience Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
708.33708.33334.13294.83246.42268.88
Revenue Growth
36.13%111.99%13.33%19.65%-8.35%58.64%
Gross Profit
265.79265.79133.3694.9597.6594.25
Operating Income
115.22115.2229.288.1128.0310.51
Net Income
41.1641.1620.052.2620.437.77
Earnings Per Share
9.599.594.670.686.812.59
EPS Growth
133.97%105.35%587.57%-90.03%162.93%370.91%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
27.6527.6517.382.94.54.8
Total Debt
174.59174.59120.561.621.4332.38
Net Cash (Debt)
-146.94-146.94-103.12-58.7-16.93-27.58
Net Cash Growth
------
Net Cash Per Share
-34.24-34.24-24.03-17.67-5.64-9.19

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.5-0.529.21-147.9811.55-4.49
Capital Expenditures
-75.18-75.18-13.72-0.07-0.14-4.67
Free Cash Flow
-75.68-75.6815.49-148.0511.41-9.15
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
37.52%37.52%39.91%32.20%39.63%35.05%
Operating Margin
16.27%16.27%8.76%2.75%11.38%3.91%
Pretax Margin
14.26%14.26%7.85%2.01%11.14%3.91%
Profit Margin
5.81%5.81%6.00%0.77%8.29%2.89%
FCF Margin
-10.69%-10.69%4.64%-50.21%4.63%-3.40%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.283.8611.50116.07--
P/FCF Ratio
--14.89---
PS Ratio
0.250.220.690.89--